The lawsuit alleges that Primoris misled shareholders regarding its internal financial health during the defined period. Specifically, the complaint claims the company’s cost estimation and project oversight processes were fundamentally flawed, leading to a systematic failure to account for material cost overruns, execution difficulties, and schedule delays within its fixed-price renewable energy portfolio. These omissions allegedly left investors without a clear picture of the company’s actual financial risks and profitability projections.

Shareholders who acquired stock during this window are eligible to participate in the litigation without incurring out-of-pocket costs, typically operating under a contingency fee arrangement. While the firm encourages investors to move the court for lead plaintiff status before the September deadline, it notes that class certification remains pending. Investors retain the right to select their own counsel, remain an absent class member, or choose not to participate at all, as serving as a lead plaintiff is not a requirement for sharing in any potential future recovery.